Strides Arcolab’s arm receives USFDA nod for two Oncology products

19 Oct 2012 Evaluate

Strides Arcolab’s - wholly owned subsidiary - Onco Therapies has received two more ANDA approvals from USFDA for Fludarabine Phosphate for Injection, USP packaged in 50 mg/ 2 mL, Single use vials (25 mg/mg/ mL upon reconstitution) -  Lyophilized format and Idarubicin Hydrochloride Injection, 1 mg/ mL -5 mL, 10 mL and 20 mL Single-dose vials. The combined market for the two drugs is approximately $20 million.

Fludarabine is a chemotherapy drug used to treat chronic lymphocytic leukemia (a type of cancer of the white blood cells) in adults.

Idarubicin belongs to the group of cancer-fighting medications known as antineoplastics. Idarubicin is used alone or in combination with other antineoplastic medications to treat leukemia.

Strides Arcolab is a global pharmaceutical company headquartered in Bangalore, India that develops and manufactures wide range of IP-lead niche pharmaceutical products with an emphasis on sterile injectables.

Strides Pharma Scien Share Price

862.85 -15.80 (-1.80%)
08-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1795.30
Dr. Reddys Lab 1267.15
Cipla 1497.45
Zydus Lifesciences 924.35
Lupin 2071.35
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×